Medical devices and technology companies continue their strong performance of late as investors look ahead to the future of healthcare. We have recently talked about a number of compelling investments in this space, such as Immunogen (NASDAQ:IMGN) and Steris Corp (NYSE:STE). The following article continues the trend and looks at the fast growing company Endologix (NASDAQ:ELGX) with an advanced patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). With over 200,000 people diagnosed in the US each year, ELGX continues to gain market share and has impressive upside capabilities over the medium term offering over 40% upside at current levels.
While 200,000 people are diagnosed each year in the US, it...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|